Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
AIntibody: an experimentally validated in silico antibody discovery design challenge.
Erasmus MF, Spector L, Ferrara F, DiNiro R, Pohl TJ, Perea-Schmittle K, Wang W, Tessier PM, Richardson C, Turner L, Kumar S, Bedinger D, Sormanni P, Fernández-Quintero ML, Ward AB, Loeffler JR, Swanson OM, Deane CM, Raybould MIJ, Evers A, Sellmann C, Bachas S, Ruffolo J, Nastri HG, Ramesh K, Sørensen J, Croasdale-Wood R, Hijano O, Leal-Lopes C, Shahsavarian M, Qiu Y, Marcatili P, Vernet E, Akbar R, Friedensohn S, Wagner R, Kurella VB, Malhotra S, Kumar S, Kidger P, Almagro JC, Furfine E, Stanton M, Graff CP, Villalba SD, Tomszak F, Teixeira AAR, Hopkins E, Dovner M, D'Angelo S, Bradbury ARM. Erasmus MF, et al. Among authors: d angelo s. Nat Biotechnol. 2024 Nov;42(11):1637-1642. doi: 10.1038/s41587-024-02469-9. Nat Biotechnol. 2024. PMID: 39496931 No abstract available.
Expect the unexpected: fulminant myocardial cytotoxic Injury from Trabectedin.
Tsay AJ, Satish M, Corley E, Ezema A, DeJesus N, Wisely S, McAleer E, Zhang C, Yuan S, Homan E, Liu JE, Weinsaft JW, D'Angelo S, Feldman SA, Chan AT. Tsay AJ, et al. Among authors: d angelo s. Cardiooncology. 2024 Oct 15;10(1):70. doi: 10.1186/s40959-024-00257-7. Cardiooncology. 2024. PMID: 39407287 Free PMC article.
Histology-specific clinical trial of lenvatinib and pembrolizumab in patients with sarcoma.
Movva S, Seier K, Avutu V, Banks LB, Chan J, Chi P, Dickson MA, Gounder MM, Kelly CM, Keohan ML, Maki R, Rosenbaum E, Salcito T, Rodriguez K, Dempsey R, Meyers PA, Cohen SM, Hensley ML, Konner JA, Schram AM, Lefkowitz RA, Erinjeri JP, Qin LX, Tap WD, D'Angelo SP. Movva S, et al. Among authors: d angelo sp. Clin Cancer Res. 2024 Oct 15. doi: 10.1158/1078-0432.CCR-24-2519. Online ahead of print. Clin Cancer Res. 2024. PMID: 39405335
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses.
Seligson ND, Chen JL, Goodrich AC, Van Tine BA, Campbell JD, Richards AL, Antonescu CR, Liebner DA, Milhem MM, Streicher H, Tap WD, Schwartz GK, George S, D'Angelo SP. Seligson ND, et al. Among authors: d angelo sp. J Immunother Cancer. 2024 Sep 28;12(9):e009472. doi: 10.1136/jitc-2024-009472. J Immunother Cancer. 2024. PMID: 39343511 Free PMC article. Clinical Trial.
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort.
Ramonda R, Lorenzin M, Chimenti MS, Atzeni F, Semeraro A, D'Angelo S, Selmi C, Ortolan A, Marchesoni A, Manara M, Luchetti Gentiloni MM, Santo L, Salvarani C, Cauli A, Rossini M, Amato G, Cozzi G, Scagnellato L, Ferraioli M, Carriero A, Fracassi E, Giorgio F, Doria A, Foti R, Carletto A; on behalf Spondyloarthritis and Psoriatic Arthritis SIR Study Group “Antonio Spadaro”. Ramonda R, et al. Among authors: d angelo s. Arthritis Res Ther. 2024 Sep 28;26(1):172. doi: 10.1186/s13075-024-03401-x. Arthritis Res Ther. 2024. PMID: 39342310 Free PMC article.
Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial.
Moon RJ, D' Angelo S, Curtis EM, Ward KA, Crozier SR, Schoenmakers I, Javaid MK, Bishop NJ, Godfrey KM, Cooper C, Harvey NC; MAVIDOS Trial Group. Moon RJ, et al. Among authors: d angelo s. Am J Clin Nutr. 2024 Nov;120(5):1134-1142. doi: 10.1016/j.ajcnut.2024.09.014. Epub 2024 Sep 19. Am J Clin Nutr. 2024. PMID: 39306330 Free article. Clinical Trial.
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability.
Ferrara F, Fanni A, Teixeira AAR, Molina E, Leal-Lopes C, DeAguero A, D'Angelo S, Erasmus MF, Spector L, Rodriguez Carnero LA, Li J, Pohl TJ, Suslov N, Desrumeaux K, McMahon C, Kathuria S, Bradbury ARM. Ferrara F, et al. Among authors: d angelo s. MAbs. 2024 Jan-Dec;16(1):2394230. doi: 10.1080/19420862.2024.2394230. Epub 2024 Aug 27. MAbs. 2024. PMID: 39192463 Free PMC article.
A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors.
Barker CA, D'Angelo SP, Wasilewski G, Steckler AM, Lian M, Zhang Z, Chapman PB, Shoushtari AN, Ariyan CE. Barker CA, et al. Among authors: d angelo sp. Radiother Oncol. 2024 Nov;200:110478. doi: 10.1016/j.radonc.2024.110478. Epub 2024 Aug 17. Radiother Oncol. 2024. PMID: 39159678 Clinical Trial.
683 results